Biopharma2021
$CGTX can’t believe 2 phase 3 blockbuster medication assets with heavy endorsement from fda and heavy nih funding and endorsement and waiting for 504 pts start trial results next year and stock price is sitting at 66 cents . I have never seen this type of bargain in my biopharma investment history . Happy friday to cgtx longs .
17

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault3.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault14.jpg)
:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_Stock_market_Image_public_domain_declining_wc_96197f57d2.jpg)